Profile data is unavailable for this security.
About the company
JCR Pharmaceuticals Co., Ltd. is a Japan-based company primarily engaged in the pharmaceutical business, as well as the medical and research equipment business. The Company operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.
- Revenue in JPY (TTM)42.87bn
- Net income in JPY5.51bn
- Incorporated1975
- Employees879.00
- LocationJCR Pharmaceuticals Co Ltd3-19, Kasuga-choASHIYA-SHI 659-0021JapanJPN
- Phone+81 797328591
- Websitehttps://www.jcrpharm.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fuji Pharma Co Ltd | 43.05bn | 5.92bn | 36.49bn | 1.62k | 6.05 | 0.8133 | 3.96 | 0.8475 | 243.57 | 243.57 | 1,771.38 | 1,812.38 | 0.5071 | 1.34 | 3.21 | 26,558,910.00 | 6.97 | 4.10 | 10.56 | 5.58 | 39.78 | 42.41 | 13.75 | 7.55 | 0.5895 | -- | 0.3826 | 31.17 | 15.42 | 1.52 | 27.41 | 0.3709 | 19.04 | 5.73 |
| Seikagaku Corp | 36.21bn | 2.19bn | 44.26bn | 976.00 | 19.44 | 0.588 | 11.36 | 1.22 | 40.08 | 40.08 | 663.80 | 1,324.81 | 0.4601 | 2.06 | 5.02 | -- | 2.78 | 0.4261 | 3.05 | 0.4678 | 46.60 | 54.18 | 6.04 | 0.9814 | 4.47 | -- | 0.0055 | 415.52 | 8.24 | 4.99 | -2.24 | -0.5224 | 30.28 | 0.00 |
| Shin Nippon Biomedical Laboratories Ltd | 26.45bn | 5.53bn | 58.49bn | 1.21k | 10.57 | 1.71 | 11.39 | 2.21 | 132.86 | 132.86 | 635.35 | 819.43 | 0.3961 | 1.24 | 5.08 | -- | 8.26 | 10.54 | 12.43 | 15.93 | 54.00 | 52.73 | 20.86 | 25.32 | 0.7835 | -- | 0.4339 | 24.21 | 5.42 | 11.05 | -8.73 | 23.18 | 50.90 | 75.54 |
| ispace Inc | 2.36bn | -2.37bn | 67.33bn | 216.00 | -- | 6.91 | -- | 28.57 | -31.36 | -31.36 | 29.06 | 104.64 | 0.1377 | 7.48 | 98.55 | -- | -13.83 | -- | -24.15 | -- | 39.38 | -- | -100.39 | -- | 2.05 | -- | 0.5623 | -- | 138.27 | -- | 79.24 | -- | -- | -- |
| Katakura Industries Co., Ltd. | 39.83bn | 3.01bn | 69.20bn | 1.04k | 21.62 | 0.8443 | 11.75 | 1.74 | 90.90 | 90.90 | 1,203.27 | 2,327.46 | 0.2858 | 2.35 | 4.49 | 38,300,000.00 | 2.29 | 2.35 | 2.99 | 3.34 | 38.30 | 37.75 | 8.01 | 8.32 | 2.58 | -- | 0.1097 | 18.81 | 16.62 | -2.04 | 8.09 | 18.87 | -7.46 | 10.76 |
| JCR Pharmaceuticals Co Ltd | 42.87bn | 5.51bn | 71.20bn | 879.00 | 12.50 | 1.22 | 9.57 | 1.66 | 43.91 | 43.91 | 342.28 | 450.13 | 0.4349 | 0.5891 | 3.29 | -- | 5.62 | 8.66 | 8.47 | 13.46 | 72.90 | 74.51 | 12.92 | 18.24 | 1.22 | 27.69 | 0.2921 | 29.60 | 24.83 | 13.11 | 46.00 | 8.19 | 18.54 | 21.67 |
| ASKA Pharmaceutical Holdings Co Ltd | 62.84bn | 7.55bn | 72.13bn | 747.00 | 8.86 | 1.08 | 8.44 | 1.15 | 266.48 | 266.48 | 2,219.59 | 2,186.08 | 0.7066 | 1.69 | 4.08 | -- | 8.48 | 4.63 | 11.08 | 5.87 | 48.80 | 46.94 | 12.01 | 6.76 | 1.49 | -- | 0.1328 | 14.42 | 3.94 | 6.12 | 78.03 | 34.04 | -37.89 | 23.36 |
| Eiken Chemical Co Ltd | 40.05bn | 2.63bn | 79.82bn | 754.00 | 29.37 | 1.56 | 18.68 | 1.99 | 70.52 | 70.52 | 1,080.89 | 1,328.72 | 0.6262 | 2.83 | 3.40 | -- | 4.12 | 8.01 | 5.06 | 10.14 | 41.76 | 45.92 | 6.58 | 11.50 | 2.62 | -- | 0.0862 | 35.21 | -7.44 | 2.29 | -54.08 | -5.24 | 11.66 | 11.20 |
| Zeria Pharmaceutical Co Ltd | 75.73bn | 7.73bn | 104.17bn | 1.73k | 11.18 | 1.09 | 7.78 | 1.38 | 175.39 | 175.39 | 1,717.90 | 1,806.33 | 0.5304 | 1.48 | 3.99 | -- | 5.39 | 3.89 | 8.39 | 6.28 | 73.29 | 71.93 | 10.16 | 7.57 | 0.7946 | 13.04 | 0.3667 | 35.00 | 10.74 | 4.14 | 24.78 | 17.49 | 20.77 | 5.29 |
| GNI Group Ltd | 27.75bn | 9.55bn | 104.96bn | 843.00 | 11.16 | 3.03 | 8.85 | 3.78 | 188.10 | 188.10 | 554.62 | 693.41 | 0.5569 | 2.01 | 7.89 | 32,921,710.00 | 22.45 | 7.23 | 26.73 | 8.80 | 84.78 | 85.75 | 40.32 | 14.57 | 2.74 | 30.59 | 0.1417 | 0.00 | 49.32 | 38.97 | 1,981.71 | -- | 19.69 | -- |
| Torii Pharmaceutical Co Ltd | 56.28bn | 5.29bn | 106.42bn | 583.00 | 19.65 | 0.8724 | 18.53 | 1.89 | 188.05 | 188.05 | 2,002.44 | 4,235.56 | 0.4288 | 2.72 | 2.25 | 96,531,740.00 | 4.03 | 6.52 | 4.44 | 7.35 | 44.83 | 49.55 | 9.40 | 17.98 | 5.58 | -- | 0.00 | 24.17 | 11.74 | -2.67 | 4.44 | 28.76 | -20.38 | 20.11 |
Data as of May 29 2024. Currency figures normalised to JCR Pharmaceuticals Co Ltd's reporting currency: Japanese Yen JPY
14.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 15 Apr 2024 | 8.11m | 6.25% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 2.84m | 2.19% |
| The Vanguard Group, Inc.as of 09 May 2024 | 2.00m | 1.54% |
| Schroder Investment Management (Japan) Ltd.as of 31 Jan 2024 | 1.09m | 0.84% |
| Nikko Asset Management Co., Ltd.as of 10 May 2024 | 1.06m | 0.81% |
| Daiwa Asset Management Co. Ltd.as of 30 Apr 2024 | 1.01m | 0.78% |
| BlackRock Fund Advisorsas of 09 May 2024 | 920.10k | 0.71% |
| Schroder Investment Management Ltd.as of 30 Jun 2023 | 760.70k | 0.59% |
| Asset Management One Co., Ltd.as of 09 May 2024 | 656.70k | 0.51% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 10 May 2024 | 561.30k | 0.43% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
